Document Detail


The absorption, excretion and influence on bowel flora of oral paromomycin sulfate (author's transl)
MedLine Citation:
PMID:  7321186     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The absorption, excretion and influence on bowel flora of oral paromomycin sulfate (aminosidine, PRM) were studied in ten normal volunteers taking a normal diet, and the following results were obtained. 1. Serum levels of PRM were observed 0.46 micrograms/ml at a half hour, 1.14 micrograms/ml at 1 hour, 1.48 micrograms/ml at 2 hours, 0.70 micrograms/ml at 4 hours, 0.29 micrograms at 6 hours and were almost faded out at 12 hours after 4 grams of oral administration. 2. During 0 approximately 2 hours, 2 approximately 4 hours, 4 approximately 6 hours and 6 approximately 12 hours, the mean urine concentration of PRM were observed 56.4 micrograms/ml, 56.2 micrograms/ml, 37.1 micrograms/ml and 13.8 micrograms/ml, respectively, and the total excretion in the urine by 12 hours were observed 21.14 mg (0.53%). 3. Oral administration of PRM caused fall in Lactobacillus, non spore-forming anaerobic Gram positive bacilli (BEP group) and Peptostreptococcus (P less than 0.001), Bacteroides (P less than 0.01). However, after administration was discontinued, reduced bowel flora was returned to the normal range within a few days. No overgrowth of bowel flora by coliform, Clostridium or yeast was observed. Klebsiella oxytoca and toxigenic Clostridium difficile were not observed overgrowth. 4. No side effect was observed clinically over 2 months.
Authors:
S Iwaki; K Honke; N Nishida; N Taniguchi
Publication Detail:
Type:  English Abstract; Journal Article    
Journal Detail:
Title:  The Japanese journal of antibiotics     Volume:  34     ISSN:  0368-2781     ISO Abbreviation:  Jpn J Antibiot     Publication Date:  1981 Jul 
Date Detail:
Created Date:  1982-03-13     Completed Date:  1982-03-13     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0154402     Medline TA:  Jpn J Antibiot     Country:  JAPAN    
Other Details:
Languages:  jpn     Pagination:  1078-81     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adult
Humans
Intestinal Absorption
Intestines / microbiology*
Paromomycin / administration & dosage*,  metabolism,  pharmacology
Chemical
Reg. No./Substance:
7542-37-2/Paromomycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effectiveness of acetylspiramycin for Mycoplasma pneumonia in children (author's transl)
Next Document:  Clinical effect of acetylspiramycin on primary atypical pneumonia in children (author's transl)